IRIS
Modica, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 875
EU - Europa 382
AS - Asia 263
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 869
IT - Italia 192
SG - Singapore 171
CN - Cina 69
NL - Olanda 68
CI - Costa d'Avorio 37
DE - Germania 30
UA - Ucraina 17
SE - Svezia 16
FI - Finlandia 15
IE - Irlanda 14
VN - Vietnam 13
FR - Francia 10
GB - Regno Unito 10
CA - Canada 6
IN - India 6
CZ - Repubblica Ceca 3
ES - Italia 2
HK - Hong Kong 2
AR - Argentina 1
CH - Svizzera 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
NP - Nepal 1
PL - Polonia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.560
Salva come PNG Salva come JPEG
Città #
Chandler 185
Singapore 142
Ashburn 125
Amsterdam 66
Naples 59
Santa Clara 30
Millbury 23
Beijing 21
Des Moines 20
Napoli 19
Seattle 18
Boston 15
Jacksonville 15
Lawrence 15
Nanjing 14
Rome 14
Princeton 13
Dong Ket 12
Washington 12
Milan 11
Wilmington 11
Munich 10
Portici 9
Kronberg 8
Nanchang 7
Houston 6
Helsinki 5
Lappeenranta 5
Los Angeles 5
Ottawa 5
Paris 5
Dublin 4
Pune 4
Boardman 3
Brno 3
Buffalo 3
Casavatore 3
Hebei 3
London 3
Philadelphia 3
Woodbridge 3
A Coruña 2
Ann Arbor 2
Bari 2
Bicester 2
Cagliari 2
Dallas 2
Fairfield 2
Frankfurt am Main 2
Hong Kong 2
Marcianise 2
Messina 2
Mosciano Sant'Angelo 2
Piano Di Sorrento 2
Pozzuoli 2
Redwood City 2
Riva del Garda 2
Scafati 2
Shenyang 2
Solaro 2
Tappahannock 2
Torre Del Greco 2
West Jordan 2
Afragola 1
Arienzo 1
Atlanta 1
Bassersdorf 1
Brindisi 1
Buenos Aires 1
Chisinau 1
Council Bluffs 1
Edinburgh 1
Forest City 1
Freiburg im Breisgau 1
Garden City 1
Giugliano In Campania 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Jiaxing 1
Johannesburg 1
Kagoya 1
Kathmandu 1
Kunming 1
Köln 1
Landshut 1
Lembach 1
Marzano di Nola 1
Mcallen 1
Mumbai 1
New Delhi 1
Norwich 1
Nuremberg 1
Palermo 1
Portland 1
Reggio Emilia 1
San Jose 1
Shenzhen 1
Spresiano 1
Staten Island 1
Totale 1.018
Salva come PNG Salva come JPEG
Nome #
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 61
Hepatic arterial embolization in patients with neuroendocrine tumors. 58
GLP-1: benefits beyond pancreas. 56
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity and Resilience 49
Pituitary function and morphology in Fabry disease. 47
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 43
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 42
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 41
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 41
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 40
Nutrition and neuroendocrine tumors: An update of the literature. 40
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 40
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 39
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 38
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors? 37
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature 36
Open issues on G3 neuroendocrine neoplasms: Back to the future 36
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 35
An incidental rectal neuroendocrine microcarcinoma ('micro-NEC') coexistent with a high grade adenoma 35
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 34
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 34
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 34
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 33
The safety of available treatments options for neuroendocrine tumors 31
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 31
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery 29
Erratum to: GLP-1: Benefits beyond pancreas 26
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies (Oct, 10.1007/s40618-022-01905-4, 2022) 25
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 21
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 21
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives 20
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study 20
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 20
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 19
A rare rarity: Neuroendocrine tumor of the esophagus 17
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target 16
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature 14
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 14
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 14
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 14
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 14
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays 13
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 13
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers 13
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 13
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 12
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 12
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 12
Risk factors for gastroenteropancreatic neuroendocrine neoplasms ({GEP}-{NENs}): a three-centric case{\textendash}control study 12
PRRT: identikit of the perfect patient 11
Prognostic significance of laterality in lung neuroendocrine tumors 11
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 11
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 11
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 10
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 10
Corrigendum to: Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience (vol 106, pg e316, 2020) 10
Carcinoma showing thymus-like differentiation (CASTLE): a case report 10
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 10
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1) 10
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 10
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus 9
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms 9
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms 9
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia 9
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature 9
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship 9
Parathyroid diseases and metabolic syndrome 8
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists 8
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 8
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons 7
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: Confirmation that R203X is the peculiar AIRE gene mutation 7
Bone metabolism and vitamin D implication in gastroenteropancreatic neuroendocrine tumors 7
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? 6
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial 6
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 6
Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker? 6
Neuroendocrine Tumors and Immune System 6
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 4
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC) 4
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead 4
Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? 3
Immune checkpoint inhibitors in cancer therapy: The leading role of the endocrinologist 3
Totale 1.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 1 6 3 0 2 1 13 12 4
2020/202191 0 5 16 10 9 13 9 1 7 2 6 13
2021/2022215 2 0 25 3 5 14 1 6 17 16 64 62
2022/2023494 31 57 14 39 51 41 54 33 50 81 41 2
2023/2024515 20 66 53 48 40 67 17 84 3 16 69 32
2024/2025217 108 83 25 1 0 0 0 0 0 0 0 0
Totale 1.676